-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Neutral on Amgen, Raises Price Target to $400

Benzinga·08/18/2026 10:58:22
Listen to the news
Cantor Fitzgerald analyst Carter Gould maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $350 to $400.